146 related articles for article (PubMed ID: 26748860)
1. Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9.
Gopalakrishnan A; Dietzold J; Salgame P
Cell Immunol; 2016 Apr; 302():11-18. PubMed ID: 26748860
[TBL] [Abstract][Full Text] [Related]
2. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
Bafica A; Scanga CA; Feng CG; Leifer C; Cheever A; Sher A
J Exp Med; 2005 Dec; 202(12):1715-24. PubMed ID: 16365150
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. Development of a secondary immune response to Mycobacterium tuberculosis is independent of Toll-like receptor 2.
McBride A; Bhatt K; Salgame P
Infect Immun; 2011 Mar; 79(3):1118-23. PubMed ID: 21173309
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection.
Zhan R; Han Q; Zhang C; Tian Z; Zhang J
Infect Immun; 2015 Apr; 83(4):1641-9. PubMed ID: 25667264
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question.
Gopalakrishnan A; Salgame P
Curr Opin Immunol; 2016 Oct; 42():76-82. PubMed ID: 27326654
[TBL] [Abstract][Full Text] [Related]
7. Mincle is not essential for controlling Mycobacterium tuberculosis infection.
Heitmann L; Schoenen H; Ehlers S; Lang R; Hölscher C
Immunobiology; 2013 Apr; 218(4):506-16. PubMed ID: 22784441
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
[TBL] [Abstract][Full Text] [Related]
9. Host defense and recruitment of Foxp3⁺ T regulatory cells to the lungs in chronic Mycobacterium tuberculosis infection requires toll-like receptor 2.
McBride A; Konowich J; Salgame P
PLoS Pathog; 2013; 9(6):e1003397. PubMed ID: 23785280
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.
Choi HG; Kim WS; Back YW; Kim H; Kwon KW; Kim JS; Shin SJ; Kim HJ
Eur J Immunol; 2015 Jul; 45(7):1957-71. PubMed ID: 25907170
[TBL] [Abstract][Full Text] [Related]
11. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
12. Navigating through the maze of TLR2 mediated signaling network for better mycobacterium infection control.
Yu X; Zeng J; Xie J
Biochimie; 2014 Jul; 102():1-8. PubMed ID: 24594065
[TBL] [Abstract][Full Text] [Related]
13. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.
Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP
Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.
Drennan MB; Nicolle D; Quesniaux VJ; Jacobs M; Allie N; Mpagi J; Frémond C; Wagner H; Kirschning C; Ryffel B
Am J Pathol; 2004 Jan; 164(1):49-57. PubMed ID: 14695318
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effects and mechanisms of CpG oligodeoxynucleotides in mice infected with Mycobacterium tuberculosis].
Ren T; Li CY; Cai YY; Jin ML; Hu YW; Yuan ZH; Tian M; Zhao B
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):87-91. PubMed ID: 16677448
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
17. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174
[TBL] [Abstract][Full Text] [Related]
18. Critical role of toll-like receptor 9 in morphine and Mycobacterium tuberculosis-Induced apoptosis in mice.
Chen L; Shi W; Li H; Sun X; Fan X; Lesage G; Li H; Li Y; Zhang Y; Zhang X; Zhang Y; Yin D
PLoS One; 2010 Feb; 5(2):e9205. PubMed ID: 20174568
[TBL] [Abstract][Full Text] [Related]
19. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.
Fremond CM; Yeremeev V; Nicolle DM; Jacobs M; Quesniaux VF; Ryffel B
J Clin Invest; 2004 Dec; 114(12):1790-9. PubMed ID: 15599404
[TBL] [Abstract][Full Text] [Related]
20. A subunit vaccine based on rH-NS induces protection against Mycobacterium tuberculosis infection by inducing the Th1 immune response and activating macrophages.
Liu Y; Chen S; Pan B; Guan Z; Yang Z; Duan L; Cai H
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):909-922. PubMed ID: 27563010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
